Philip Morris stock edges higher after new contract manufacturing deal

Philip Morris International Inc. (ISIN US7181721090) stock is trading close to $188 per share as of August 24, 2026, with investors reacting to a newly announced contract manufacturing collaboration with Altria that is set to start generating shipments in early 2027 while leaving 2026 expectations unchanged. This arrangement provides a fresh strategic angle on Philip Morris International's combustible cigarette operations without altering the company’s focus on smoke-free alternatives.

New manufacturing agreement with Altria

On August 24, 2026, Philip Morris International announced that its non-U.S. affiliates have entered into a contract manufacturing arrangement for combustible cigarettes with Philip Morris USA, an operating company of Altria. The Business Wire announcement states that the first shipments under this arrangement are expected to begin early in 2027, subject to operational readiness and regulatory approvals. Importantly, the company notes that it does not expect a material impact on its 2026 financials from this agreement, signaling that the deal is structured as a medium-term operational optimization rather than an immediate earnings driver.

The arrangement allows Altria to enhance efficiency in its traditional tobacco product operations by leveraging Philip Morris International’s manufacturing capacity outside the United States. A related news report notes that Altria’s subsidiary Philip Morris USA entered into this contract manufacturing arrangement with non-U.S. affiliates of Philip Morris International to improve cost efficiency for its combustible portfolio. Both companies indicate that they do not expect the agreement to affect financial performance in 2026, reinforcing the message that the key impact will be felt after shipments commence in 2027.

Stock reaction, price levels and valuation context

Philip Morris International shares on the New York Stock Exchange were indicated at $188.14 at the start of the latest regular session, according to a series of institutional holding updates that reference this opening level on Monday August 24, 2026. One such institutional filing update notes that Philip Morris International stock opened at $188.14 on that day, characterizing the move as trading down 0.0 percent, which effectively signals a flat start versus the prior close. A separate cross-market snapshot highlights that Philip Morris International traded at $189.80 in pre-market activity, up 0.84 percent, and that the most recent official closing price stood at $188.23, with the shares down 1.72 percent on the day and up 17.35 percent since the beginning of the year as of that closing reference. A market overview shows this $188.23 closing level alongside the 17.35 percent year-to-date gain, indicating that Philip Morris International has delivered a mid-teens percentage return from the start of 2026 to the latest completed session.

On the valuation side, one equity research platform’s GF Value framework estimates an intrinsic value for Philip Morris International of $158.09 compared with a current market price of $193.38, resulting in a calculated overvaluation of 22.3 percent on that specific metric. The analysis highlights that at a share price of $193.38, Philip Morris International trades above this GF Value estimate, suggesting that the stock is fully valued to moderately rich relative to this intrinsic benchmark. For investors, the contrast between the GF Value of $158.09 and the market price of $193.38 underscores a sizable premium of $35.29 per share within that model, even as the stock’s 17.35 percent year-to-date increase points to strong performance in 2026.

Consensus expectations remain constructive despite valuation concerns. Several recent institutional holdings reports reference aggregated analyst data indicating that Philip Morris International is covered with an average rating classified as Moderate Buy and a consensus price target of $205.89, compared with the current trading range in the high $180s to low $190s. One such consensus overview cites this $205.89 average target, implying upside of roughly $12 to $17 per share versus the latest quoted price range. That spread aligns with the view that while Philip Morris International shares are not cheap by some intrinsic-value measures, analysts still see scope for further appreciation driven by cash generation and the company’s reduced-risk product portfolio.

Recent performance, fundamentals and guidance framework

While detailed second-quarter or half-year 2026 numbers are not fully laid out in the latest day-filtered sources, the available coverage makes clear that Philip Morris International’s most recent fundamental picture is framed by continued growth in smoke-free products and resilient cash flows from its legacy combustible operations. The company positions itself as a global tobacco and nicotine player whose product portfolio includes conventional cigarettes as well as smoke-free alternatives designed for adult smokers seeking reduced-risk options. A market profile underscores that Philip Morris International’s offerings span cigarettes, other nicotine-containing products and a growing family of smoke-free devices and consumables, and that the company is headquartered in Stamford, Connecticut.

From a guidance standpoint, Philip Morris International explicitly states in its August 24, 2026 manufacturing collaboration release that it does not expect this new arrangement with Philip Morris USA to materially affect 2026 financials. That means the company’s existing outlook for revenue, earnings and margins in 2026 effectively remains unchanged, with the new contract manufacturing deal treated as a neutral overlay in the short term. The same Business Wire release emphasizes that Philip Morris International has not commercialized combustible cigarettes in the United States and has no plans to do so, reinforcing that the arrangement is operational rather than a strategic pivot toward the US domestic cigarette market. This nuance matters for investors concerned that the collaboration might signal a reversal of the company’s focus on reduced-risk products and international markets; the company’s statement suggests that its reduced-risk strategy remains intact while it monetizes manufacturing expertise via third-party arrangements.

Analyst commentary captured in the institutional holding updates continues to lean constructive. One such overview reports that Philip Morris International is followed with 10 Buy ratings and two Hold ratings, which feed into the Moderate Buy consensus classification. Combined with the average target of $205.89, this implies that analysts view the shares’ current level in the high $180s as a base for potential gains, assuming execution on smoke-free growth, stable cash flows from combustibles and disciplined capital allocation. The GF Value warning on possible overvaluation and dividend sustainability challenges provides a counterpoint, introducing a debate between valuation models and sell-side price targets that investors can weigh when assessing whether the current premium is justified by Philip Morris International’s growth trajectory and risk profile.

IQOS and smoke-free product strategy

Beyond combustible cigarettes and manufacturing collaborations, Philip Morris International’s strategic narrative centers on smoke-free alternatives, led by its IQOS heated tobacco system and related consumables. The company describes its product portfolio as including smoke-free products designed to give adult smokers alternatives to traditional cigarettes, aiming to reduce exposure to harmful substances while preserving nicotine delivery. The market profile notes that these smoke-free offerings constitute a growing share of Philip Morris International’s global sales mix, reinforcing its long-term ambition to pivot away from conventional cigarettes.

From an investment perspective, the central question is how effectively Philip Morris International can continue scaling IQOS and other reduced-risk platforms while maintaining strong cash flow from its combustible base and now adding contract manufacturing revenues from arrangements like the new Altria deal. The announced manufacturing collaboration does not alter Philip Morris International’s lack of US commercialization for combustible cigarettes; instead, it uses non-U.S. affiliates to produce products that Philip Morris USA can then deploy in its own markets. That distinction protects Philip Morris International’s stated strategic focus while potentially opening incremental revenue streams once shipments begin in early 2027.

Shares and current market snapshot

Philip Morris International stock is listed on the New York Stock Exchange under the ticker PM and quoted in US dollars. As of the latest completed trading session referenced in the available sources, the shares closed at $188.23, with intraday indications in the current session showing an opening level of $188.14 and pre-market pricing at $189.80, which corresponds to a modest gain of 0.84 percent versus the prior day. This combined quote and performance snapshot also shows that Philip Morris International shares are up 17.35 percent since the start of 2026, reflecting solid appreciation over the year amid ongoing progress in smoke-free products and steady demand for combustible offerings.

Given the current closing level of $188.23 and the GF Value estimate of $158.09, investors face the trade-off between a strong historical and year-to-date performance curve and a valuation model that flags a 22.3 percent premium to intrinsic value. Meanwhile, the analyst consensus target of $205.89 sits well above the latest trading range, hinting that sell-side forecasts see room for further gains if Philip Morris International delivers its growth and margin expectations and if the new manufacturing collaborations and smoke-free initiatives enhance earnings power after 2026.

Go deeper

More on Philip Morris International stock

Investor Relations

IQOS heated tobacco platform

Philip Morris International’s IQOS heated tobacco platform is a flagship smoke-free product that exemplifies the company’s strategic pivot toward reduced-risk alternatives. IQOS devices heat specially designed tobacco sticks instead of burning them, which the company asserts significantly reduces levels of certain harmful chemicals compared with conventional cigarette smoke. Over recent years, IQOS adoption across multiple markets has become a key driver of Philip Morris International’s volume mix and revenue diversification, and the company sees the platform as central to its vision of a smoke-free future.

Philip Morris stock and investor takeaway

As of August 24, 2026, Philip Morris International stock trades around $188 per share, with the most recent closing price at $188.23 and intraday indications showing minor positive moves in pre-market trading. The shares have gained 17.35 percent year to date, highlighting resilient performance supported by the growth of smoke-free products and stable legacy operations. Against this backdrop, investors are weighing a new contract manufacturing collaboration with Altria that begins shipments in early 2027, carries no expected material impact on 2026 financials and reinforces Philip Morris International’s role as a global manufacturing partner for combustible products without changing its lack of US commercialization. With an analyst consensus price target of $205.89 and a GF Value estimate of $158.09 contrasting on valuation, the stock sits at the intersection of strong recent returns, a visible strategic evolution toward smoke-free offerings and a debate over how much future growth is already reflected in the current share price.

Fact box

Company: Philip Morris International Inc.

ISIN: US7181721090

Ticker: PM

Exchange: New York Stock Exchange

Price (as of August 23, 2026, 10:00 p.m. ET): $188.23 USD

Market cap: $293 billion (as of August 23, 2026)

Sector / Industry: Consumer Staples / Tobacco

Index membership: S&P 500